New Study Reveals Link Between Fibromyalgia and Insulin Resistance in Chronic Pain Syndrome
A recent scientific study has found that Fibromyalgia is not only associated with long-term pain but also closely linked to metabolic disorders, particularly insulin resistance. The findings were published in 2026 by Rehan Haider and colleagues from University of Karachi, Dow University of Health Sciences, SBB Dewan University, and OPJS University. Published in the International Journal of Applied and Scientific Research, the article suggests that metabolic dysfunction may be one of the factors worsening fibromyalgia symptoms. Fibromyalgia has long been recognized as a condition characterized by widespread body pain, severe fatigue, sleep disturbances, and difficulty concentrating. However, this new research indicates that these symptoms may not stem solely from the nervous system but may also be influenced by how the body regulates blood sugar and insulin. The findings are significant because they open a new perspective on understanding a chronic disease that has long been difficult to explain fully. If insulin resistance truly plays a role in fibromyalgia, patient care may expand beyond pain management to include metabolic treatment.
A recent scientific study has found that Fibromyalgia is not only associated with long-term pain but also closely linked to metabolic disorders, particularly insulin resistance. The findings were published in 2026 by Rehan Haider and colleagues from University of Karachi, Dow University of Health Sciences, SBB Dewan University, and OPJS University. Published in the International Journal of Applied and Scientific Research, the article suggests that metabolic dysfunction may be one of the factors worsening fibromyalgia symptoms. Fibromyalgia has long been recognized as a condition characterized by widespread body pain, severe fatigue, sleep disturbances, and difficulty concentrating. However, this new research indicates that these symptoms may not stem solely from the nervous system but may also be influenced by how the body regulates blood sugar and insulin. The findings are significant because they open a new perspective on understanding a chronic disease that has long been difficult to explain fully. If insulin resistance truly plays a role in fibromyalgia, patient care may expand beyond pain management to include metabolic treatment.
Fibromyalgia May Be Closely Related to Body Metabolism
Fibromyalgia affects approximately 2–4 percent of the global population and is more common in women. Patients typically experience widespread muscle pain, prolonged fatigue, poor sleep quality, and cognitive problems often referred to as “brain fog.” For years, fibromyalgia was mainly understood as a central nervous system disorder that amplifies pain sensitivity. The new study adds another dimension: metabolic dysfunction. Insulin resistance occurs when body cells no longer respond properly to insulin, disrupting glucose uptake. This condition is usually associated with diabetes, but the study shows that insulin resistance can also occur in fibromyalgia patients who do not have diabetes.
Research Method: Comparing Patients With Healthy Individuals
The research team used an observational cross-sectional design. A total of 60 fibromyalgia patients aged 18–65 were compared with 60 healthy individuals matched by age and sex. Participants with a history of Type 2 Diabetes, cardiovascular disease, or autoimmune disorders were excluded. The collected data included:
-body weight and body mass index (BMI),
-fasting blood glucose,
-fasting insulin levels,
-HOMA-IR score to assess insulin resistance,
-pain severity,
-fatigue severity,
-inflammatory biomarkers.
This approach allowed researchers to directly examine the relationship between metabolic abnormalities and fibromyalgia symptom severity.
Main Findings: Fibromyalgia Patients Show Higher Insulin Resistance
The results revealed clear differences between fibromyalgia patients and the healthy control group.
Key findings include:
-average fasting insulin in fibromyalgia patients was 18.4 μIU/mL, compared with 10.2 μIU/mL in healthy controls,
-HOMA-IR score in patients reached 4.1, while controls averaged 2.3,
-fasting blood glucose in patients was 102 mg/dL, compared with 95 mg/dL in controls,
-pain and fatigue levels increased alongside higher insulin resistance.
The researchers also found that HOMA-IR scores were positively correlated with:
-pain severity (r = 0.48),
-fatigue severity (r = 0.52).
This means that the greater the insulin resistance, the more severe the symptoms experienced by fibromyalgia patients.
Chronic Inflammation May Be the Missing Link
The study highlights chronic low-grade inflammation as a likely mechanism connecting fibromyalgia and insulin resistance.
Fibromyalgia patients in the study had significantly higher inflammatory biomarkers, especially:
-TNF-α at 12.4 pg/mL,
-IL-6 at 10.8 pg/mL,
which were much higher than those in healthy participants.
These molecules are known to interfere with insulin signaling and increase pain sensitivity in the nervous system. As a result, the body may enter a vicious cycle: inflammation worsens insulin resistance, insulin resistance impairs energy production, and both together intensify pain and fatigue.
Implications: Fibromyalgia Treatment Could Change
The findings open new opportunities for treating fibromyalgia. If metabolic dysfunction contributes to symptoms, therapy may no longer focus only on pain relief.
The researchers highlight several possible strategies:
-structured aerobic exercise,
-dietary interventions to improve insulin sensitivity,
-medications such as Metformin,
-anti-inflammatory therapies.
Rehan Haider states that metabolic assessment should become part of routine evaluation for fibromyalgia patients. This approach could help physicians address underlying causes rather than just symptoms.
Impact on Healthcare
This study may reshape how physicians understand fibromyalgia. A disease previously considered primarily a neurological pain disorder may now be viewed as a multisystem condition involving metabolism.For society, the findings are important because they may:
-improve early diagnosis,
-expand treatment options,
-enhance patient quality of life,
-reduce the long-term burden of chronic pain.
If further validated, the research may also influence healthcare policies by encouraging metabolic screening as part of standard fibromyalgia care.
Author Profiles
Rehan Haider
Lead researcher from University of Karachi specializing in metabolic disorders, chronic pain, and biomedical sciences.
Zameer Ahmed, Hina Abbas, and Sambreen Zameer
Researchers from Dow University of Health Sciences focusing on metabolic disease and chronic clinical conditions.
Shabana Naz Shah
Academic from SBB Dewan University with expertise in clinical pharmacy.
Geetha Kumari Das
Researcher from OPJS University specializing in metabolic health and pharmaceutical therapy.
Rehan Haider
Lead researcher from University of Karachi specializing in metabolic disorders, chronic pain, and biomedical sciences.
Zameer Ahmed, Hina Abbas, and Sambreen Zameer
Researchers from Dow University of Health Sciences focusing on metabolic disease and chronic clinical conditions.
Shabana Naz Shah
Academic from SBB Dewan University with expertise in clinical pharmacy.
Geetha Kumari Das
Researcher from OPJS University specializing in metabolic health and pharmaceutical therapy.
Research Source
“Fibromyalgia and General Insulin Resistance: Investigating Metabolic Dysregulation in Chronic Pain Syndrome”
Published in International Journal of Applied and Scientific Research, 2026.
This article is based on the scientific paper:
Official DOI: https://doi.org/10.59890/ijasr.v4i3.210
“Fibromyalgia and General Insulin Resistance: Investigating Metabolic Dysregulation in Chronic Pain Syndrome”
Published in International Journal of Applied and Scientific Research, 2026.
This article is based on the scientific paper:
Official DOI: https://doi.org/10.59890/ijasr.v4i3.210
0 Komentar